platinox-v
vitamed pharmaceutical industries ltd - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg / 1 ml - oxaliplatin - oxaliplatin in combination with 5- fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumour. - treatment of metastatic colorectal cancer.oxaliplatin in combination with leucovorin, irinotecan and 5-fluorouracil is indicated for the first line treatment of patients with metastatic pancreatic adenocarcinoma (based on nccn guidelines, version 2.2014).
lansina 30 capsule
ibn sina pharmaceutical ind. ltd. - lansoprazole - capsule - 30 mg
lansinoh for breastfeeding mothers
egnell ameda limited - wool fat - ointment
platinol-aq
bristol-myers squibb (nz) limited - cisplatin 1 mg/ml; - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml
platinol 10mg vial
bristol-myers squibb-egypt - injection - 10 mg/20ml
platinol 50mg vial
bristol-myers squibb-egypt - injection - 50 mg
platinox 50 mg lyophilized powder for i.v. infusion
qualimed pharm, inc.; distributor: qualimed pharm, inc. - oxaliplatin - lyophilized powder for i.v. infusion - 50 mg
platinol aq inj 1mg/ml liquid
bristol labs division of bristol-myers squibb - cisplatin - liquid - 1mg - cisplatin 1mg - antineoplastic agents
platinor 90 mg tablet
healthcare pharmaceuticals ltd. - ticagrelor - tablet - 90 mg
platinox 100 mg lyophilized powder for injection (i.v. infusion)
qualimed pharma, inc.; distributor: qualimed pharma, inc. - oxaliplatin - lyophilized powder for injection (i.v. infusion) - 100 mg